|Articles|August 9, 2013

Researchers Suggest Camels Implicated in MERS-CoV Outbreak

Researchers who were searching for signs of Middle East respiratory syndrome coronavirus (MERS-CoV) in different livestock animals have found antibodies specific to the new virus in dromedary camels. This suggests that these animals have encountered MERS-CoV, or a closely related virus, and may be one reservoir of the virus that is causing MERS in humans. The results of this study, led by RIVM-researchers, were published today in The Lancet Infectious Diseases.

Reusken, et al. (2013) extracted sera from animals in the Middle East and from Spain, Netherlands and Chile. Cattle, sheep, goats, dromedary camels and other camelid species were tested for specific serum IgG by protein microarray using the receptor-binding S1 subunits of spike proteins of MERS-CoV, severe acute respiratory syndrome coronavirus, and human coronavirus OC43. Results were confirmed by virus neutralization tests for MERS-CoV and bovine coronavirus.

The researchers found that 100 percent of sera from Middle Eastern camels and 14 percent from Spanish camels had protein-specific antibodies against MERS-CoV spike. Sera from European sheep, goats, cattle, and other camelids had no such antibodies. The researchers say that MERS-CoV or a related virus has infected camel populations, and that titres and seroprevalences in sera from different locations in the Middle East suggest widespread infection.

Reference: Reusken C, et al. Middle East respiratory syndrome coronavirus neutralising serum antibodies in dromedary camels: a comparative serological study. The Lancet Infectious Diseases, Early Online Publication, Aug. 9, 2013 doi:10.1016/S1473-3099(13)70164-6


Related to this article

Water  (Adobe Stock 456102510 by stockphoto-graf)
Understanding current water quality is a starting point for ST108 implementation. John Kimsey, vice president of processing optimization and customer success for STERISS, spoke about his HSPA presentation on assessing readiness, distinguishing system qualification from routine testing, and understanding where water samples should be collected.
Image of Pathogens flying   (Adobe Stock weerasak)
Behind every landmark in infection prevention, from antimicrobial stewardship guidelines to the COVID-19 town halls that reached flight attendants and teachers, is a generation of physician-scientists who led SHEA through crises, organizational change, and scientific breakthroughs. Infection Control Today traces 30 years of SHEA presidents and the lasting mark they left on the field.
AORN26 New Orleans 2026  (Adobe Stock)
Missing instruments and processing delays can strain OR–SPD relationships. At AORN 2026, John Kimsey, vice president of processing optimization and customer success for STERIS, discusses understanding root causes, exploring off-site reprocessing for ambulatory surgical centers, and using hands-on simulation to help surgical teams see sterile processing from a different perspective.